2 - TI Pharma
2 - TI Pharma 2 - TI Pharma
Figure 3. A two-week treatment with prednisolone increased area under the postprandial glucose curve (panel A: placebo; panel B: prednisolone), despite increased C-peptide levels (panel C: placebo; panel D: prednisolone). Solid line with black squares represents day 0, dotted line with white squares represents day 15. Date are mean ± SEM. Figure 4. A 15-day treatment with prednisolone decreased the basal secretory tone and potentiation factor ratio (panel B and C). Glucose sensitivity and rate sensitivity were not affected (panel A and D). Graphs are Box-and-Whisker plots with median and interquartile range. * P
- Page 116: Chapter 3 Glucocorticoids induce be
- Page 120: Chapter 3 Glucocorticoids induce be
- Page 124: Chapter 3 Glucocorticoids induce be
- Page 128: Chapter 3 Glucocorticoids induce be
- Page 132: Chapter 3 Glucocorticoids induce be
- Page 136: Chapter 3 Glucocorticoids induce be
- Page 140: Chapter 3 Glucocorticoids induce be
- Page 144: Chapter 3 Glucocorticoids induce be
- Page 152: Chapter 4 Glucocorticoids impair be
- Page 156: Chapter 4 Glucocorticoids impair be
- Page 160: Chapter 4 Glucocorticoids impair be
- Page 164: Chapter 4 Glucocorticoids impair be
- Page 170: prednisolone, as the most widely pr
- Page 174: REFERENCES 1. Schacke H, Docke WD,
- Page 182: Chapter 5 Islet-cell Dysfunction In
- Page 186: Glucocorticoids (GCs) are the corne
- Page 190: Hyperinsulinemic-euglycemic clamp a
- Page 194: called the potentiation factor rati
- Page 198: iAUC: β=0.126; P=0.638; R 2 =0.119
- Page 202: Figure 3. Postprandial responses at
- Page 206: Safety and tolerability: One subjec
- Page 210: towards withdrawal of vagal activit
- Page 214: REFERENCES 1. Schacke H, Docke WD,
Figure 3. A two-week treatment with prednisolone increased area under the postprandial glucose curve<br />
(panel A: placebo; panel B: prednisolone), despite increased C-peptide levels (panel C: placebo; panel D:<br />
prednisolone). Solid line with black squares represents day 0, dotted line with white squares represents<br />
day 15. Date are mean ± SEM.<br />
Figure 4. A 15-day treatment with prednisolone decreased the basal secretory tone and potentiation<br />
factor ratio (panel B and C). Glucose sensitivity and rate sensitivity were not affected (panel A and D).<br />
Graphs are Box-and-Whisker plots with median and interquartile range. * P
Change language